Sage Therapeutics Inc (SAGE) Return on Investment ROI from the second quarter of 2025 to second quarter of 2024 and for the year 2025, average high and low, overall ranking from Jun 30 2025 to Jun 30 2024 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Sage Therapeutics Inc   (NASDAQ: SAGE)


Sage Therapeutics Inc's ROI from its second quarter of 2025 to the second quarter of 2024 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Sage Therapeutics Inc's ROI in the second quarter of 2025?
Sage Therapeutics Inc recorded a cumulative net loss of $-301 million during 12 months ending in the second quarter of 2025, resulting in a negative return on investment (ROI) of -65.63%.

Within the Healthcare sector 545 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Jun 30 2025 quarter, so far to 3582, from total ROI ranking in the first quarter of 2025 at 3613.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter		 (Dec 31 2024)
IV. Quarter		 (Sep 30 2024)
III. Quarter		 (Jun 30 2024)
II. Quarter
Y / Y Investment Change TTM -37.77 % -36.94 % -36.55 % -35.75 % -38.09 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 378 420 476 562 628
Return On Investment (TTM) -65.63 % -67.97 % -67.58 % -50.1 % -60.43 %
SAGE's Overall Ranking # 3582 # 3613 # 2346 # 3468 # 3739
Seq. Investment Change TTM -11.98 % -12.06 % -12.02 % -8.63 % -10.81 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -301 -354 -401 -338 -446

SAGE Company Profile >> Back to SAGE Roi Comparisons >> See Annual SAGE Return On Investment



Return On Investment SAGE's Ranking
Within: No.
Industry # 235
Sector # 546
Overall # 3582

Return On Investment Statistics
High Average Low
54.99 %
-39.03 %
-89.17 %
(Dec 31 2020)   (Sep 30 2017)







Financial Statements
Sage Therapeutics Inc's II. Quarter Investments $ 378 Millions SAGE's Balance sheet
Sage Therapeutics Inc's II. Quarter Income $ -50 Millions Quarterly SAGE's Income Statement
SAGE's Income by Division See SAGE's Income by Division


SAGE Annual Return On Investment (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2020)
2020
Total Investments in Millions 476 800 1,257 1,740 2,092
Y / Y Investment Growth -40.51 % -36.4 % -27.75 % -16.82 % 115.23 %
Net Income in Millions -401 -541 -533 -458 606
Y / Y Net Income Growth - - - - -
Annual Return On Investment -84.24 % -67.73 % -42.38 % -26.31 % 28.97 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
SAGE's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for SAGE's Competitors
Subscribers only: Roi for Sage Therapeutics Inc's Suppliers
Subscribers only: Return On Investment for SAGE's Customers

Other Ratios
SAGE's Roa SAGE's Inventory Turnover Ratio SAGE's Growth Rates SAGE's Dividend Statistics
SAGE's Profitability Ratios SAGE's Asset Turnover Ratio SAGE's Dividend Growth
SAGE's Roe SAGE's Valuation Ratios SAGE's Financial Strength Ratios SAGE's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2025, within Healthcare Sector ROI

Date modified: 2026-09-18T13:11:06+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.